• 1. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
• 4. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 5. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Hydropyridines Pyridinones

Introduction to 3-(2-Oxopyridin-1(2H)-yl)propanoic acid (CAS No. 68634-48-0) and Its Emerging Applications in Chemical Biology

3-(2-Oxopyridin-1(2H)-yl)propanoic acid, identified by the chemical identifier CAS No. 68634-48-0, is a heterocyclic compound that has garnered significant attention in the field of chemical biology due to its unique structural properties and potential biological activities. This compound belongs to the class of pyridine derivatives, which are widely recognized for their diverse pharmacological applications. The presence of both an oxopyridine moiety and a propanoic acid side chain endows this molecule with distinct chemical and biological characteristics, making it a valuable scaffold for drug discovery and molecular research.

The structure of 3-(2-Oxopyridin-1(2H)-yl)propanoic acid features a pyridine ring substituted at the 2-position with a carbonyl group (oxopyridine), which is further linked to a propanoic acid moiety at the 3-position. This arrangement creates a molecule with potential for multiple interactions with biological targets, including enzymes and receptors. The oxopyridine group is particularly noteworthy, as it has been shown to exhibit inhibitory effects on various metabolic pathways, while the propanoic acid side chain provides a site for further functionalization, enabling the development of more complex derivatives.

In recent years, there has been a surge in research focused on pyridine-based compounds due to their broad spectrum of biological activities. Studies have demonstrated that pyridine derivatives can serve as potent inhibitors of kinases, proteases, and other enzymes involved in cancer progression, inflammation, and infectious diseases. Among these derivatives, 3-(2-Oxopyridin-1(2H)-yl)propanoic acid has emerged as a promising candidate for further exploration. Its ability to modulate enzyme activity while maintaining structural stability makes it an attractive molecule for therapeutic development.

One of the most compelling aspects of 3-(2-Oxopyridin-1(2H)-yl)propanoic acid is its potential as a drug lead in the treatment of neurological disorders. Recent studies have highlighted the role of pyridine derivatives in modulating neurotransmitter systems, particularly in conditions such as Alzheimer's disease and Parkinson's disease. The oxopyridine moiety in this compound has been found to interact with specific amino acid residues in target proteins, leading to altered enzyme kinetics that could potentially reverse or mitigate symptoms associated with these disorders.

The synthesis of 3-(2-Oxopyridin-1(2H)-yl)propanoic acid has been optimized through various methodologies, including multi-step organic reactions that introduce the necessary functional groups while maintaining high yields and purity. Advances in synthetic chemistry have enabled researchers to produce this compound in scalable quantities, facilitating its use in both preclinical and clinical studies. The development of efficient synthetic routes has also allowed for the rapid modification of its structure, leading to libraries of derivatives with tailored biological properties.

From a biological perspective, 3-(2-Oxopyridin-1(2H)-yl)propanoic acid has shown promise in inhibiting certain enzymes that are overexpressed in cancer cells. For instance, studies have indicated that it can interfere with the activity of tyrosine kinases, which are critical regulators of cell growth and survival. By blocking these kinases, the compound may induce apoptosis or arrest cell proliferation, offering a potential therapeutic strategy against various malignancies. Additionally, its ability to cross the blood-brain barrier suggests that it could be developed into treatments for central nervous system disorders.

The pharmacokinetic properties of 3-(2-Oxopyridin-1(2H)-yl)propanoic acid are also under investigation. Researchers are evaluating its solubility, stability, and metabolic pathways to determine how it behaves within the body. Understanding these parameters is crucial for optimizing dosages and minimizing side effects. Preliminary data suggest that the compound exhibits moderate solubility in water and oil-based media, which could influence its absorption and distribution after administration.

In conclusion, 3-(2-Oxopyridin-1(2H)-yl)propanoic acid (CAS No. 68634-48-0) represents a significant advancement in chemical biology research due to its unique structure and multifaceted biological activities. Its potential applications in treating neurological disorders, cancer, and other diseases make it a compelling subject for further investigation. As synthetic methodologies continue to improve and our understanding of its biological mechanisms deepens, this compound is poised to play an increasingly important role in drug discovery and development.

• 102675-58-1(1-(3-Aminopropyl)-2(1H)-pyridinone)
• 50990-45-9(2(1H)-Pyridinone,1-(6-hydroxyhexyl)-)
• 78823-57-1(1(2H)-Pyridinehexanoic acid, 2-oxo-)
• 19006-63-4(1-Propyl-2(1H)-pyridinone)
• 859296-04-1(3-(6-Methyl-2-oxopyridin-1(2H)-yl)propanoic acid)
• 78823-59-3(1(2H)-Pyridinepropanoic acid, 4-heptyl-2-oxo-)
• 27361-14-4(2(1H)-Pyridinone,1-butyl-)
• 78838-03-6(1(2H)-Pyridineundecanoic acid, 2-oxo-)
• 1094475-34-9(ethyl 3-(2-oxopyridin-1(2H)-yl)propanoate)
• 878775-97-4(3-(2-Oxo-2H-pyridin-1-yl)-propionicacidhydrobromide)